S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Crescent Energy (CRGY) Stock Price, News & Analysis

$10.97
+0.18 (+1.67%)
(As of 04/19/2024 08:50 PM ET)
Today's Range
$10.72
$11.09
50-Day Range
$10.49
$12.00
52-Week Range
$9.17
$14.22
Volume
927,800 shs
Average Volume
1.35 million shs
Market Capitalization
$1.97 billion
P/E Ratio
8.50
Dividend Yield
4.38%
Price Target
$16.25

Crescent Energy MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
48.1% Upside
$16.25 Price Target
Short Interest
Bearish
11.45% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
1.02mentions of Crescent Energy in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$136.21 M Sold Last Quarter
Proj. Earnings Growth
61.22%
From $0.98 to $1.58 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.84 out of 5 stars

Oils/Energy Sector

7th out of 231 stocks

Crude Petroleum & Natural Gas Industry

1st out of 72 stocks

CRGY stock logo

About Crescent Energy Stock (NYSE:CRGY)

Crescent Energy Company, an energy company, acquires, develops, and produces crude oil, natural gas, and natural gas liquids (NGLs) reserves. The company holds a portfolio of oil and natural gas assets in key proven regions, including the Eagle Ford, Marcellus, Utica, and Rockies in the United States. The company is based in Houston, Texas.

CRGY Stock Price History

CRGY Stock News Headlines

Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Analyst Scoreboard: 4 Ratings For Crescent Energy
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Shhh! 7 Small-Cap Stocks That Can Double by 2025
CRGY Apr 2024 7.500 put
See More Headlines
Receive CRGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescent Energy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/04/2024
Ex-Dividend for 3/28 Dividend
3/14/2024
Dividend Payable
3/28/2024
Today
4/22/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Crude petroleum & natural gas
Sub-Industry
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.25
High Stock Price Target
$19.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+48.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$67.61 million
Pretax Margin
14.49%

Debt

Sales & Book Value

Annual Sales
$2.38 billion
Cash Flow
$4.92 per share
Book Value
$9.65 per share

Miscellaneous

Free Float
155,942,000
Market Cap
$1.97 billion
Optionable
Optionable
Beta
2.24
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

CRGY Stock Analysis - Frequently Asked Questions

Should I buy or sell Crescent Energy stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Crescent Energy in the last twelve months. There are currently 1 hold rating, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRGY shares.
View CRGY analyst ratings
or view top-rated stocks.

What is Crescent Energy's stock price target for 2024?

7 brokerages have issued 12 month target prices for Crescent Energy's shares. Their CRGY share price targets range from $13.00 to $19.00. On average, they predict the company's share price to reach $16.25 in the next year. This suggests a possible upside of 48.1% from the stock's current price.
View analysts price targets for CRGY
or view top-rated stocks among Wall Street analysts.

How have CRGY shares performed in 2024?

Crescent Energy's stock was trading at $13.21 on January 1st, 2024. Since then, CRGY stock has decreased by 17.0% and is now trading at $10.97.
View the best growth stocks for 2024 here
.

Are investors shorting Crescent Energy?

Crescent Energy saw a increase in short interest in March. As of March 15th, there was short interest totaling 9,640,000 shares, an increase of 6.2% from the February 29th total of 9,080,000 shares. Based on an average trading volume of 1,140,000 shares, the short-interest ratio is currently 8.5 days. Approximately 11.9% of the shares of the company are short sold.
View Crescent Energy's Short Interest
.

When is Crescent Energy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our CRGY earnings forecast
.

How were Crescent Energy's earnings last quarter?

Crescent Energy (NYSE:CRGY) released its quarterly earnings data on Monday, March, 4th. The company reported $0.58 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.37. The firm earned $657.73 million during the quarter, compared to the consensus estimate of $584.12 million. Crescent Energy had a net margin of 2.84% and a trailing twelve-month return on equity of 13.30%.

How often does Crescent Energy pay dividends? What is the dividend yield for Crescent Energy?

Crescent Energy declared a quarterly dividend on Monday, March 4th. Stockholders of record on Friday, March 15th will be given a dividend of $0.12 per share on Thursday, March 28th. This represents a $0.48 dividend on an annualized basis and a yield of 4.38%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for CRGY
.

Is Crescent Energy a good dividend stock?

Crescent Energy (NYSE:CRGY) pays an annual dividend of $0.48 per share and currently has a dividend yield of 4.38%. CRGY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 37.21%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CRGY will have a dividend payout ratio of 30.38% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CRGY.

Who are Crescent Energy's major shareholders?

Crescent Energy's stock is owned by a number of institutional and retail investors. Top institutional investors include Northside Capital Management LLC (0.21%), CFM Wealth Partners LLC (0.03%), Sunbelt Securities Inc. (0.02%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include Benjamin Conner, Brandi Kendall, David C Rockecharlie, Energy Aggregator Independence, John Clayton Rynd, Karen Jo Simon, Kkr Group Partnership LP, Retirement System Of T Teacher and Todd Falk.
View institutional ownership trends
.

How do I buy shares of Crescent Energy?

Shares of CRGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CRGY) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners